BioMarin Pharmaceuticals BMRN Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's prepaid & other current?
- BioMarin Pharmaceuticals (BMRN) reported prepaid & other current of $205.5M in Q1 2026.
- How has BioMarin Pharmaceuticals's prepaid & other current changed year-over-year?
- BioMarin Pharmaceuticals's prepaid & other current increased by 13.2% year-over-year, from $181.55M to $205.5M.
- What is the long-term trend for BioMarin Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's prepaid & other current has grown at a 7.4% compound annual growth rate (CAGR), from $129.93M to $185.78M.
- What does prepaid & other current mean?
- Payments made in advance for future services or other assets that will be used within a year.
- How do you interpret prepaid & other current?
- Significant fluctuations may indicate changes in the scale of upcoming operational activities or shifts in vendor payment terms.
- How does prepaid & other current compare across companies?
- Generally a small portion of current assets, consistent across the pharmaceutical industry.